Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

An ENU-mutagenesis screen in the mouse: identification of novel developmental gene functions.

Wansleeben C, van Gurp L, Feitsma H, Kroon C, Rieter E, Verberne M, Guryev V, Cuppen E, Meijlink F.

PLoS One. 2011 Apr 29;6(4):e19357. doi: 10.1371/journal.pone.0019357.

2.

Genotype-based screen for ENU-induced mutations in mouse embryonic stem cells.

Chen Y, Yee D, Dains K, Chatterjee A, Cavalcoli J, Schneider E, Om J, Woychik RP, Magnuson T.

Nat Genet. 2000 Mar;24(3):314-7.

PMID:
10700191
3.

Genome-wide ENU mutagenesis in combination with high density SNP analysis and exome sequencing provides rapid identification of novel mouse models of developmental disease.

Caruana G, Farlie PG, Hart AH, Bagheri-Fam S, Wallace MJ, Dobbie MS, Gordon CT, Miller KA, Whittle B, Abud HE, Arkell RM, Cole TJ, Harley VR, Smyth IM, Bertram JF.

PLoS One. 2013;8(3):e55429. doi: 10.1371/journal.pone.0055429.

4.

Characterization of mutant spectra generated by a forward mutational assay for gene A of Phi X174 from ENU-treated transgenic mouse embryonic cell line PX-2.

Valentine CR, Montgomery BA, Miller SG, Delongchamp RR, Fane BA, Malling HV.

Environ Mol Mutagen. 2002;39(1):55-68.

PMID:
11813297
5.

Efficient gene-driven germ-line point mutagenesis of C57BL/6J mice.

Michaud EJ, Culiat CT, Klebig ML, Barker PE, Cain KT, Carpenter DJ, Easter LL, Foster CM, Gardner AW, Guo ZY, Houser KJ, Hughes LA, Kerley MK, Liu Z, Olszewski RE, Pinn I, Shaw GD, Shinpock SG, Wymore AM, Rinchik EM, Johnson DK.

BMC Genomics. 2005 Nov 21;6:164.

6.

Ethylnitrosourea-induced mutation and molecular analysis of transgenic mice containing the gpt shuttle vector.

Yamada T, Yamamoto R, Kaneko H, Yoshitake A.

Mutat Res. 1999 Apr 26;441(1):59-72.

PMID:
10224323
7.
8.

Identification of novel genetic loci for bone size and mechanosensitivity in an ENU mutant exhibiting decreased bone size.

Srivastava AK, Kapur S, Mohan S, Yu H, Kapur S, Wergedal J, Baylink DJ.

J Bone Miner Res. 2005 Jun;20(6):1041-50.

9.
10.

Diabetes models by screen for hyperglycemia in phenotype-driven ENU mouse mutagenesis projects.

Aigner B, Rathkolb B, Herbach N, Hrabé de Angelis M, Wanke R, Wolf E.

Am J Physiol Endocrinol Metab. 2008 Feb;294(2):E232-40. Review.

12.
13.
14.

Hypercholesterolemia in ENU-induced mouse mutants.

Mohr M, Klempt M, Rathkolb B, de Angelis MH, Wolf E, Aigner B.

J Lipid Res. 2004 Nov;45(11):2132-7.

15.

Implementation of a large-scale ENU mutagenesis program: towards increasing the mouse mutant resource.

Nolan PM, Peters J, Vizor L, Strivens M, Washbourne R, Hough T, Wells C, Glenister P, Thornton C, Martin J, Fisher E, Rogers D, Hagan J, Reavill C, Gray I, Wood J, Spurr N, Browne M, Rastan S, Hunter J, Brown SD.

Mamm Genome. 2000 Jul;11(7):500-6.

PMID:
10886012
16.

The novel mouse mutant, chuzhoi, has disruption of Ptk7 protein and exhibits defects in neural tube, heart and lung development and abnormal planar cell polarity in the ear.

Paudyal A, Damrau C, Patterson VL, Ermakov A, Formstone C, Lalanne Z, Wells S, Lu X, Norris DP, Dean CH, Henderson DJ, Murdoch JN.

BMC Dev Biol. 2010 Aug 12;10:87. doi: 10.1186/1471-213X-10-87.

18.
19.

Efficient generation and mapping of recessive developmental mutations using ENU mutagenesis.

Herron BJ, Lu W, Rao C, Liu S, Peters H, Bronson RT, Justice MJ, McDonald JD, Beier DR.

Nat Genet. 2002 Feb;30(2):185-9.

PMID:
11818962
20.

Mutational pattern and frequency of induced nucleotide changes in mouse ENU mutagenesis.

Takahasi KR, Sakuraba Y, Gondo Y.

BMC Mol Biol. 2007 Jun 20;8:52.

Items per page

Supplemental Content

Support Center